• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压最新情况:老年人

Hypertension Update: Older Adults.

作者信息

Viera Anthony J

机构信息

Department of Community and Family Medicine Duke University School of Medicine, Box 2914 DUMC, Durham, NC 27710.

出版信息

FP Essent. 2018 Jun;469:26-29.

PMID:29863320
Abstract

Hypertension is prevalent in older adults, and blood pressure (BP) level lowering has been shown to be one of the most important clinical interventions to reduce the risk of cardiovascular events. The goal BP level for older adults is individualized based on age, cardiovascular risk, overall health status (particularly frailty), and patient preferences. Recent guidelines differ but a goal systolic BP level lower than 150 mm Hg is reasonable for nearly all adults 60 years and older. In patients with isolated systolic hypertension, the degree to which systolic BP level lowering can be tolerated may be limited if the diastolic BP level decreases below 60 to 65 mm Hg. Orthostatic hypotension is common among older hypertensive patients. Symptoms of light-headedness should prompt an evaluation for orthostatic hypotension and a possible decrease in drug treatment. For relatively healthy older adults at increased cardiovascular risk, a systolic BP level goal lower than 140 mm Hg may be pursued. Although more aggressive BP level lowering is associated with a greater decrease in the number of cardiovascular events, it also is associated with a higher number of adverse events.

摘要

高血压在老年人中很常见,降低血压水平已被证明是降低心血管事件风险的最重要临床干预措施之一。老年人的目标血压水平根据年龄、心血管风险、整体健康状况(尤其是虚弱程度)和患者偏好进行个体化设定。近期的指南有所不同,但对于几乎所有60岁及以上的成年人来说,收缩压目标水平低于150 mmHg是合理的。在单纯收缩期高血压患者中,如果舒张压水平降至60至65 mmHg以下,收缩压降低所能耐受的程度可能会受到限制。体位性低血压在老年高血压患者中很常见。头晕症状应促使对体位性低血压进行评估,并可能减少药物治疗。对于心血管风险增加的相对健康的老年人,可以追求收缩压水平目标低于140 mmHg。虽然更积极地降低血压水平与心血管事件数量的更大减少相关,但也与更高的不良事件数量相关。

相似文献

1
Hypertension Update: Older Adults.高血压最新情况:老年人
FP Essent. 2018 Jun;469:26-29.
2
Diastolic Hypotension in a Tertiary Care Hypertension Clinic: Have We Gone Too Far?三级高血压诊所中的舒张压低:我们做得太过了吗?
Can J Cardiol. 2016 May;32(5):695-700. doi: 10.1016/j.cjca.2015.08.026. Epub 2015 Sep 4.
3
Should blood pressure goal be individualized in hypertensive patients?高血压患者的血压目标应该个体化吗?
Pharmacol Res. 2017 Apr;118:53-63. doi: 10.1016/j.phrs.2016.11.037. Epub 2016 Dec 2.
4
Treatment of Hypertension: Which Goal for Which Patient?高血压的治疗:针对不同患者应设定何种目标?
Adv Exp Med Biol. 2017;956:117-127. doi: 10.1007/5584_2016_97.
5
Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients.超越指南:个体化使用抗高血压药物治疗老年患者。
Drugs Aging. 2019 Aug;36(8):675-685. doi: 10.1007/s40266-019-00683-8.
6
[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].老年患者中难以控制的动脉高血压。“白大衣效应”的意义
Rev Port Cardiol. 1999 Oct;18(10):897-906.
7
Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trial.依那普利保护复发性卒中研究(PROGRESS)试验:降压治疗对单纯舒张期高血压患者主要血管事件的影响。
Stroke. 2011 Aug;42(8):2339-41. doi: 10.1161/STROKEAHA.110.606764. Epub 2011 Jun 23.
8
On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.老年单纯收缩期高血压患者治疗期间的血压与心血管结局
Hypertension. 2017 Feb;69(2):220-227. doi: 10.1161/HYPERTENSIONAHA.116.08600. Epub 2017 Jan 3.
9
Prevalence and persistency of orthostatic blood pressure fall in older patients with isolated systolic hypertension. Syst-Eur Investigators.老年单纯收缩期高血压患者直立性血压下降的患病率及持续性。 Syst-Eur研究人员。
J Hum Hypertens. 1996 Sep;10(9):607-12.
10
Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.动态血压与诊室血压用于评估临床试验中抗高血压疗效:来自Val-Syst研究的见解
Clin Ther. 2004 Sep;26(9):1436-45. doi: 10.1016/j.clinthera.2004.09.003.